How ISO 27001 Enhances Security & Compliance for Genetic Data

Introduction

Genetic data generated through Next-Generation Sequencing (NGS) is highly sensitive and requires stringent security measures. Laboratories, research institutions, and biotech companies must protect this data from unauthorised access, cyber threats, and data breaches while ensuring compliance with regulatory frameworks. However, securing vast volumes of genomic data while maintaining operational efficiency and regulatory alignment presents significant challenges.

For organisations handling NGS data, ensuring confidentiality, integrity, and availability is a business and compliance imperative. This is where ISO/IEC 27001, the international standard for information security management systems (ISMS), plays a critical role. ISO 27001 provides a systematic approach to information security management, helping organisations implement structured policies, access controls, encryption methods, and risk management strategies. By adhering to ISO 27001, NGS facilities can strengthen data protection, enhance regulatory compliance, and mitigate cybersecurity risks in genomic research and diagnostics.

This article explores how ISO 27001 enhances the security and compliance of NGS data, ensuring its confidentiality, integrity, and availability in genomic analysis workflows.

What is ISO 27001?

ISO 27001 is an internationally recognised standard that outlines best practices for establishing, operating, and continually strengthening an Information Security Management System aligned with an organisation’s context and objectives. It defines a structured, risk-based approach for identifying, evaluating, and treating information security risks, ensuring the confidentiality, integrity, and availability of sensitive data.

The standard is designed to be universally applicable, regardless of an organisation’s size, type, or industry, making it highly adaptable to complex environments such as genomic research and diagnostics. In the context of NGS, where genetic data is both personally identifiable and biologically sensitive, ISO 27001 provides a consistent framework to mitigate risks such as unauthorised access, data breaches, and improper use of sequencing datasets through tailored controls and continuous improvement.

While ISO/IEC 27001 defines the requirements for establishing, operating, and improving an Information Security Management System (ISMS), ISO/IEC 27002:2022 provides the detailed guidance to meet those requirements. It describes a comprehensive set of information security, cybersecurity, and privacy protection controls that organisations can select and tailor based on their risk assessment.

Key ISO 27001 Measures for Protecting Genetic Data

Risk assessment and control measures: Identifies potential security threats in NGS data processing and storage and applies mitigation controls.
Access control: Restricts access to authorised personnel, minimising the risk of data leaks, manipulation, or unauthorised sharing.
Data encryption: Protects genetic data at rest and in transit, ensuring security during storage, transmission, and cross-platform integration.
Incident management: Establishes detection, reporting, and response mechanisms for handling cybersecurity threats, breaches, and unauthorised data access.
Regulatory compliance: Aligns with GDPR, HIPAA, and IVDR, ensuring legal and ethical handling of sensitive biological information.

By implementing ISO 27001, laboratories, research institutions, and biotech companies handling genetic data can establish a structured, regulatory-compliant security framework that minimizes risk, enhances trust, and ensures data protection across genomic workflows.

Key Security Challenges in NGS Data

NGS generates vast amounts of highly sensitive genetic data, making secure storage, controlled access, and regulatory compliance essential. Protecting this data is critical due to its personally identifiable nature and potential for misuse. However, several security challenges complicate NGS data protection and management.

1. Large-Scale Data Storage and Transfer Risks

NGS generates datasets ranging from gigabytes to several terabytes, requiring secure storage infrastructure and efficient data transfer mechanisms. The key challenges include:

Data Storage: Secure on-premise and cloud-based solutions must incorporate encryption, redundancy, and controlled access to prevent unauthorised access and data loss.
Data Transfer: Moving large genomic datasets across networks poses risks of interception, data corruption, and regulatory non-compliance if security measures are inadequate.

2. Privacy Risks and Ethical Considerations

NGS data contains unique genetic markers that can be linked to individuals and their relatives. Unauthorised access or leaks can result in:

Privacy Violations: Exposure to personal health information can lead to discrimination, insurance misuse, and employment risks.
De-Identification Challenges: Unlike standard medical records, anonymising genomic data while preserving research value is complex and requires advanced techniques.
Strict Access Controls: Implementing multi-factor authentication (MFA) and role-based access controls (RBAC) minimizes unauthorised access to genetic databases.

3. Compliance with Multi-Layered Regulations

Genetic data is governed by multiple regulatory frameworks, each focusing on different aspects of data security and patient safety:

GDPR (Europe): Emphasises data protection and patient consent for genomic data processing.
HIPAA (U.S.): Ensures the confidentiality and integrity of patient-related genomic data.
IVDR (EU): Regulates the safety and reliability of diagnostic tools used in NGS-based testing.
ISO 13485 Compliance: Ensures that NGS-related IVD medical devices and software meet strict quality control standards, a prerequisite for IVDR certification.
External Quality Assurance (EQA): Programs like EQA also known as Proficiency Testing (PT) run by the organisations EMQN and GenQA enhance cross-laboratory standardisation and ensure compliance with international standards.

4. Cybersecurity Threats and Data Breaches

NGS data is a high-value target for cyber attacks, increasing the risks of:

Ransomware and Data Theft: Cybercriminals target genomic databases for financial gain or misuse.
Malware Attacks: Unsecured laboratory IT infrastructure is vulnerable to phishing, malware, and unauthorised access attempts.
Incident Response and Recovery: Organisations must establish incident detection, reporting, and mitigation plans to address security breaches proactively.

Addressing These Challenges

To mitigate these risks, NGS facilities, diagnostic labs, and research institutions must implement ISO 27001-aligned security measures, including:

1. Strong Access Control and Identity Management

ISO 27001 requires organisations to implement strict access controls based on the principle of least privilege. For genetic data, this means:

Limiting access to sequencing data, raw reads, and variant files to authorised roles only
Enforcing MFA for systems storing or processing NGS data
Regularly reviewing and revoking access when roles change

This significantly reduces the risk of insider threats and unauthorised data exposure.

2. Encryption of Data at Rest and in Transit

Genetic data is valuable both in storage and during transmission. ISO 27001 emphasizes cryptographic controls to protect data throughout its lifecycle, including:

Encryption of NGS datasets stored in databases, file systems, and cloud environments
Secure transmission protocols when sharing data between labs, partners, or analysis pipelines
Key management policies to ensure encryption keys are protected and rotated

Encryption helps ensure that even if data is intercepted or accessed improperly, it remains unusable.

3. Risk-Based Security Management

One of ISO 27001’s greatest strengths is its risk-based approach. Organisations must:

Identify information assets such as raw sequencing data, annotated genomes, and metadata
Assess risks related to data breaches, loss, or unauthorised modification
Apply controls proportionate to the sensitivity and impact of genetic data exposure

This ensures that security efforts are focused where the risks are highest, rather than applying generic controls.

4. Compliance with Global Data Protection Regulations

ISO 27001 does not replace legal requirements, but it strongly supports compliance with regulations such as:

GDPR (EU), by enforcing data minimisation, access control, and breach management
HIPAA (USA), through safeguards for confidentiality and integrity of health-related genetic data
Local and international research regulations, particularly for cross-border data transfers

Certification provides external validation that your organisation follows internationally accepted best practices.

5. Incident Response and Breach Preparedness

Genetic data breaches can have irreversible consequences. ISO 27001 mandates documented and tested incident response procedures, including:

Clear roles and responsibilities during a security incident
Rapid detection and containment of breaches
Communication and reporting processes aligned with regulatory timelines

Being prepared reduces downtime, limits damage, and demonstrates accountability to stakeholders.

6. Secure Collaboration and Third-Party Management

NGS workflows often involve external partners, cloud providers, and bioinformatics vendors. ISO 27001 requires organisations to assess and manage third-party risks by:

Defining security requirements in contracts
Monitoring supplier compliance
Ensuring genetic data shared externally remains protected

This is especially critical when data crosses organisational or geographic boundaries.

A robust security framework for NGS data combines end-to-end encryption for data at rest and in transit, strict access controls such as RBAC and MFA, and regular regulatory audits to maintain compliance with GDPR, HIPAA, and IVDR. The use of automated tools like omnomicsV for validation and omnomicsNGS further strengthens security, data quality, and compliance. Together, these measures reduce the risk of breaches and privacy violations while ensuring data integrity, regulatory adherence, and responsible genomic research.

How ISO 27001 Secures NGS Data

1. Access Control

Protecting NGS data requires a combination of digital and physical access controls to prevent unauthorised access, data misuse, equipment tampering, and environmental threats. ISO/IEC 27001 integrates these controls to safeguard genetic data wherever it is stored, processed, or accessed.

Digital access control is enforced through RBAC and MFA. RBAC limits user permissions to defined job responsibilities, ensuring that researchers, bioinformaticians, and system administrators only access data and functions necessary for their roles. MFA adds an additional layer of protection by requiring multiple forms of identity verification, reducing the risk of credential-based attacks.

MFA strengthens security by requiring users to verify their identity through multiple authentication factors. A typical setup combines:

Something the user knows (password)
Something the user has (security token, mobile authentication app)
Something the user is (biometric verification, such as fingerprint or facial recognition)

This prevents unauthorised access, even if login credentials are compromised.

To further enhance security, audit logging mechanisms record all access attempts and modifications to genetic data. These logs track:

Who accessed the data
What actions were performed
When these actions occurred

Physical access control protects facilities such as data centers, laboratories, and secure storage areas. Measures include controlled entry using biometric or RFID systems, surveillance and monitoring, and visitor management procedures to ensure only authorised personnel can access NGS facilities.

To support accountability and threat detection, audit logging and monitoring track access attempts and data-related activities, enabling the identification of anomalies or unauthorised behavior.

Environmental safeguards further protect NGS infrastructure through fire suppression systems, backup power supplies, and climate controls to maintain system availability and equipment integrity.

Together, these controls enforce the principle of least privilege, strengthen resilience against both digital and physical threats, and support compliance with ISO 27001 requirements for secure and regulated handling of genetic data.

2. Cryptography

Cryptography plays a foundational role in securing NGS data under ISO 27001. Genetic information is highly sensitive, and unauthorised access, tampering, or leakage can have severe ethical, legal, and scientific consequences. To mitigate these risks, ISO 27001 mandates strong cryptographic controls to ensure data confidentiality and integrity in both storage (data at rest) and transmission (data in transit).

Encryption is the primary method used to protect NGS data. When stored, encryption converts raw genetic data into an unreadable format, which can only be decrypted with a secure cryptographic key. This ensures that even if an attacker gains physical or network access, the data remains inaccessible. During transmission, encryption protects data moving between sequencing platforms, bioinformatics pipelines, and cloud storage, preventing interception or eavesdropping.

Strong encryption standards such as AES-256 (Advanced Encryption Standard with a 256-bit key) provide robust protection and are widely adopted for securing genomic databases.

However, effective encryption also requires proper cryptographic key management to prevent unauthorised decryption. If encryption keys are mishandled, the security of genetic data is compromised. Secure key management involves:

Storing encryption keys separately from encrypted data to prevent unauthorised access.
Using Hardware Security Modules (HSMs) or Key Management Systems (KMS) for secure key generation, storage, and lifecycle management.
Enforcing strict access controls to limit key usage to authorised personnel and systems.
Regularly rotating encryption keys to minimize long-term exposure risks.

A well-implemented cryptographic strategy not only secures NGS data but also ensures compliance with international regulations, including GDPR, HIPAA, and IVDR. Genomic analysis platforms, such as omnomicsNGS, integrate strong encryption mechanisms to protect variant interpretation data while ensuring compliance with regulatory standards.

3. Secure Operations

Ensuring the secure operation of systems processing NGS data is essential for protecting its integrity, confidentiality, and availability. ISO 27001 establishes operational controls to detect, mitigate, and prevent security threats, ensuring continuous system protection against vulnerabilities.

Regular security updates and patch management are critical for addressing software vulnerabilities in NGS pipelines, genomic databases, and bioinformatics tools. Unpatched systems are prone to exploitation, leading to unauthorised access or data corruption. To enhance security, organisations should:

Implement automated patch deployment to reduce the risk of human error and delayed updates.
Establish a structured patch management policy, including scheduled updates to mitigate newly discovered threats.
Conduct pre-deployment testing to ensure that patches do not disrupt critical NGS workflows.

Intrusion detection and continuous monitoring are key to identifying unauthorised access attempts or suspicious activity within genomic data systems. Advanced security information and event management (SIEM) tools analyse network traffic, system logs, and access records in real time. Effective security monitoring should include the following:

Real-time alerting mechanisms to notify security teams of potential breaches.
Behavioral analytics to detect anomalous activities, such as unauthorised data transfers or unusual access patterns.
Periodic log audits to identify security gaps and refine threat detection strategies.

5. Third-party Security

Many organisations handling NGS data rely on third-party vendors and cloud service providers for data storage, processing, and variant interpretation. However, outsourcing these tasks introduces security risks that must be proactively managed to prevent data breaches and ensure regulatory compliance. ISO 27001 establishes guidelines for securing external partnerships and enforcing vendor accountability.

Before engaging a third-party provider, organisations should conduct comprehensive security assessments to ensure compliance with ISO 27001, GDPR, and HIPAA. Evaluations should include:

Data protection policies and access control mechanisms to verify the secure handling of genomic datasets.
Encryption protocols are used to protect NGS data at rest and in transit.
Incident response capabilities to assess how vendors handle security breaches and data recovery.
Compliance with quality management, ensuring that vendors meet the necessary standards for medical and IVD device development.

To enforce continuous security, organisations should:

Require vendors to maintain ISO 27001 certification and provide regular security compliance reports.
Conduct periodic security audits to verify adherence to data protection standards.
Evaluate storage and processing infrastructures for vulnerabilities and ensure strong encryption and access controls.

Legal agreements play a crucial role in ensuring accountability. Contracts should define strict data protection obligations, covering:

Data ownership and access restrictions to prevent unauthorised sharing.
Breach notification requirements, mandating that vendors report security incidents immediately.
Penalties for non-compliance, ensuring that contractual obligations are enforced.

Tools such as omnomicsV for validation and omnomicsNGS for variant interpretation work with third-party service providers that operate in accordance with genomic security and quality assurance standards.

Compliance Aspects of ISO 27001 for Genetic Data

Ensuring compliance with data protection regulations is critical for organisations handling NGS data, as genetic information is both highly sensitive and subject to strict legal requirements. ISO 27001 provides a structured framework that enables organisations to align with global regulatory mandates, demonstrating their commitment to data security, privacy, and ethical handling of genomic data.

Genetic data is governed by multiple legal and ethical frameworks, each with a specific focus. ISO 27001’s risk-based approach helps organisations implement technical and procedural controls that support compliance with the following key regulations:

General Data Protection Regulation (GDPR) – Enforces stringent safeguards for personal and genetic data within the European Union. Organisations handling genomic data must implement technical and organisational security measures to prevent unauthorised access and misuse.
Health Insurance Portability and Accountability Act (HIPAA) – Regulates the protection of patient health information (PHI) in the United States, including genetic data used in clinical diagnostics. ISO 27001 supports HIPAA compliance by establishing security controls that meet HIPAA’s administrative, physical, and technical safeguards for data confidentiality and integrity.
In Vitro Diagnostic Regulation (IVDR) – Focuses on ensuring the safety and performance of diagnostic products, including those used in NGS-based testing. Compliance with ISO 13485, which governs medical and IVD device development, is a prerequisite for IVDR certification. Laboratories handling NGS data for clinical applications must integrate ISO 27001 security controls to protect patient data while ensuring regulatory adherence.
Country-Specific Genetic Data Regulations – Many countries have national laws governing the collection, storage, and sharing of genetic data. ISO 27001 provides a flexible framework that allows organisations to adapt to evolving legal requirements while maintaining global security standards.

Achieving ISO 27001 certification serves as verifiable proof of regulatory compliance for organisations processing genetic data. An independent accredited certification body evaluates an organisation’s security policies, risk management practices, and data protection measures to confirm adherence to ISO 27001. By implementing ISO 27001, organisations handling NGS data can establish a robust security framework that meets regulatory obligations, ensures data integrity, and maintains ethical standards in genomic research and diagnostics.

Conclusion

Protecting NGS data requires both robust security measures and strict regulatory compliance. ISO 27001 provides a structured framework to achieve this, addressing access controls, encryption, operational security, physical protections, and third-party risk management. Its implementation not only mitigates risks but also ensures alignment with legal and ethical obligations. The increasing value and sensitivity of genetic data make security a long-term priority. A well-executed ISO 27001 strategy strengthens trust, safeguards data integrity, and supports continued scientific and clinical advancements.

Euformatics is a leading provider of genomic data analysis and quality management solutions, offering end-to-end tools that enhance NGS security and compliance. By integrating ISO 27001-aligned security measures, Euformatics ensures that genetic data remains protected while meeting regulatory requirements such as GDPR, HIPAA, and IVDR. To simplify cost estimation, Euformatics provides a transparent Genomics Hub price configurator, allowing laboratories to customize pricing based on their specific NGS validation, quality control, and analysis needs. Explore the pricing tool here.

Book a demo today to see how Euformatics can help secure and streamline your NGS data workflows.

FAQ

Does ISO 27001 Cover Data Protection?

Yes, ISO 27001 provides a framework for managing security risks and ensuring data confidentiality, integrity, and availability. While it doesn’t specifically address genetic data, it helps protect NGS data through access controls, encryption, and compliance with regulations like GDPR.

What Is the ISO 27001 Data Security Policy?

It defines how an organisation protects sensitive data, including NGS data, using encryption, access controls, and risk management. It ensures security, compliance, and protection against breaches.

What Is the Difference Between FedRAMP and ISO 27001?

FedRAMP is a United States federal government-wide compliance program that provides a standardised approach to security assessment, authorisation, and continuous monitoring for cloud products and services, while ISO 27001 is a global security standard applicable across industries. ISO 27001 is key for protecting NGS data through strong security controls and risk management.

What Is the ISO 27001 Standard for Information Security?

ISO 27001 is an international standard for managing information security. It protects NGS data through risk-based controls, encryption, and continuous monitoring, ensuring compliance and safeguarding genetic information.

How Does ISO 27001 Help Protect Genetic Data?

It secures genetic data by implementing access controls, encryption, and risk assessments. Organisations can protect NGS data from cyber threats and breaches while ensuring regulatory compliance and continuous security improvements.

References

Clayton, Ellen Wright, Barbara J. Evans, James W. Hazel, and Mark A. Rothstein. “The law of genetic privacy: applications, implications, and limitations.” Journal of Law and the Biosciences 6, no. 1 (2019): 1-36.
Martinez-Martin, Nicole, and David Magnus. “Privacy and ethical challenges in next-generation sequencing.” Expert review of precision medicine and drug development 4, no. 2 (2019): 95-104.

Back to news listing